88 related articles for article (PubMed ID: 19773163)
1. Inhibitor profiling of the Pseudomonas aeruginosa virulence factor LasB using N-alpha mercaptoamide template-based inhibitors.
Cathcart GR; Gilmore BF; Greer B; Harriott P; Walker B
Bioorg Med Chem Lett; 2009 Nov; 19(21):6230-2. PubMed ID: 19773163
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the binding specificity of two bacterial metalloproteases, LasB of Pseudomonas aeruginosa and ZapA of Proteus mirabilis, using N-alpha mercaptoamide template-based inhibitor analogues.
Carson L; Cathcart GR; Ceri H; Walker B; Gilmore BF
Biochem Biophys Res Commun; 2012 Jun; 422(2):316-20. PubMed ID: 22575503
[TBL] [Abstract][Full Text] [Related]
3. Structural Requirements of
Velázquez-Libera JL; Murillo-López JA; F de la Torre A; Caballero J
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817391
[TBL] [Abstract][Full Text] [Related]
4. Crystallographic structures of the elastase of Pseudomonas aeruginosa.
McKay DB; Thayer MM; Flaherty KM; Pley H; Benvegnu D
Matrix Suppl; 1992; 1():112-5. PubMed ID: 1480011
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive inhibitor profiling of the Proteus mirabilis metalloprotease virulence factor ZapA (mirabilysin).
Carson L; Cathcart GR; Scott CJ; Hollenberg MD; Walker B; Ceri H; Gilmore BF
Biochimie; 2011 Oct; 93(10):1824-7. PubMed ID: 21762758
[TBL] [Abstract][Full Text] [Related]
6. The specificity of carboxypeptidase Y may be altered by changing the hydrophobicity of the S'1 binding pocket.
Sørensen SB; Breddam K
Protein Sci; 1997 Oct; 6(10):2227-32. PubMed ID: 9336845
[TBL] [Abstract][Full Text] [Related]
7. Disarming Pseudomonas aeruginosa virulence factor LasB by leveraging a Caenorhabditis elegans infection model.
Zhu J; Cai X; Harris TL; Gooyit M; Wood M; Lardy M; Janda KD
Chem Biol; 2015 Apr; 22(4):483-491. PubMed ID: 25892201
[TBL] [Abstract][Full Text] [Related]
8. Binding Mode Characterization and Early in Vivo Evaluation of Fragment-Like Thiols as Inhibitors of the Virulence Factor LasB from Pseudomonas aeruginosa.
Kany AM; Sikandar A; Haupenthal J; Yahiaoui S; Maurer CK; Proschak E; Köhnke J; Hartmann RW
ACS Infect Dis; 2018 Jun; 4(6):988-997. PubMed ID: 29485268
[TBL] [Abstract][Full Text] [Related]
9. Solvent-stable Pseudomonas aeruginosa PseA protease gene: identification, molecular characterization, phylogenetic and bioinformatic analysis to study reasons for solvent stability.
Gupta A; Ray S; Kapoor S; Khare SK
J Mol Microbiol Biotechnol; 2008; 15(4):234-43. PubMed ID: 17715461
[TBL] [Abstract][Full Text] [Related]
10. The specificity of clostripain from Clostridium histolyticum. Mapping the S' subsites via acyl transfer to amino acid amides and peptides.
Ullmann D; Jakubke HD
Eur J Biochem; 1994 Aug; 223(3):865-72. PubMed ID: 8055964
[TBL] [Abstract][Full Text] [Related]
11. Pseudomonas aeruginosa elastase (LasB) as a therapeutic target.
Everett MJ; Davies DT
Drug Discov Today; 2021 Sep; 26(9):2108-2123. PubMed ID: 33676022
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and structure-activity relationships of gelatinase inhibitors derived from matlystatins.
Tamaki K; Tanzawa K; Kurihara S; Oikawa T; Monma S; Shimada K; Sugimura Y
Chem Pharm Bull (Tokyo); 1995 Nov; 43(11):1883-93. PubMed ID: 8575029
[TBL] [Abstract][Full Text] [Related]
13. The Leu-3 residue of Serratia marcescens metalloprotease inhibitor is important in inhibitory activity and binding with Serratia marcescens metalloprotease.
Bae KH; Kim IC; Kim KS; Shin YC; Byun SM
Arch Biochem Biophys; 1998 Apr; 352(1):37-43. PubMed ID: 9521810
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.
Esser CK; Bugianesi RL; Caldwell CG; Chapman KT; Durette PL; Girotra NN; Kopka IE; Lanza TJ; Levorse DA; MacCoss M; Owens KA; Ponpipom MM; Simeone JP; Harrison RK; Niedzwiecki L; Becker JW; Marcy AI; Axel MG; Christen AJ; McDonnell J; Moore VL; Olszewski JM; Saphos C; Visco DM; Hagmann WK
J Med Chem; 1997 Mar; 40(6):1026-40. PubMed ID: 9083493
[TBL] [Abstract][Full Text] [Related]
15. Specificity mapping of HIV-1 protease by reduced bond inhibitors.
Majer P; Urban J; Gregorová E; Konvalinka J; Novek P; Stehlíková J; Andreánsky M; Sedlácek J; Strop P
Arch Biochem Biophys; 1993 Jul; 304(1):1-8. PubMed ID: 8323274
[TBL] [Abstract][Full Text] [Related]
16. Studies on the subsite specificity of the rat brain puromycin-sensitive aminopeptidase.
Johnson GD; Hersh LB
Arch Biochem Biophys; 1990 Feb; 276(2):305-9. PubMed ID: 2306097
[TBL] [Abstract][Full Text] [Related]
17. Aza-amino acid scanning of secondary structure suited for solid-phase peptide synthesis with fmoc chemistry and aza-amino acids with heteroatomic side chains.
Boeglin D; Lubell WD
J Comb Chem; 2005; 7(6):864-78. PubMed ID: 16283795
[TBL] [Abstract][Full Text] [Related]
18. Identification of a novel secreted protease from Pseudomonas aeruginosa that causes corneal erosions.
Marquart ME; Caballero AR; Chomnawang M; Thibodeaux BA; Twining SS; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3761-8. PubMed ID: 16186360
[TBL] [Abstract][Full Text] [Related]
19. Tackling Pseudomonas aeruginosa Virulence by a Hydroxamic Acid-Based LasB Inhibitor.
Kany AM; Sikandar A; Yahiaoui S; Haupenthal J; Walter I; Empting M; Köhnke J; Hartmann RW
ACS Chem Biol; 2018 Sep; 13(9):2449-2455. PubMed ID: 30088919
[TBL] [Abstract][Full Text] [Related]
20. Novel inhibitors of the Pseudomonas aeruginosa virulence factor LasB: a potential therapeutic approach for the attenuation of virulence mechanisms in pseudomonal infection.
Cathcart GR; Quinn D; Greer B; Harriott P; Lynas JF; Gilmore BF; Walker B
Antimicrob Agents Chemother; 2011 Jun; 55(6):2670-8. PubMed ID: 21444693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
